转变生长因子-β路径:生物功能和治疗目标
Reham Hassan Mekky1, Mohammed E Abo-El Fetoh2, Safaa A Faheem2
1Department of Pharmacognosy Faculty of Pharmacy Egyptian Russian University Badr City Cairo Egypt.
MedComm
|June 30, 2025
概括
自然化合物通过向转化生长因子-β (TGF-β) 途径,在癌症治疗中表现有前途. 这些天然产品调节TGF-β信号传递,提供潜在的补充疗法,以改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 癌症进展涉及异常细胞生长和转移,通常受转化生长因子-β (TGF-β) 途径的影响.
- TGF-β通路在癌症中起着双重作用,最初抑制瘤,但后来促进进展和转移.
- 由于其生物活性和低毒性,天然化合物提供了潜在的治疗策略.
研究的目的:
- 审查自然产品在调节TGF-β信号传递中对抗癌效应的治疗潜力.
- 评估自然产品对TGF-β和癌症进展的影响的临床前和临床研究.
- 探索天然化合物作为针对TGF-β通路的补充性癌症疗法.
主要方法:
- 临床前和临床研究的文献综述.
- 评估天然产品对TGF-β调节的影响.
- 对癌症特征的影响分析,如扩散,亡和血管生成.
主要成果:
- 天然化合物,包括金氏化物,藻和表甲基酸盐,调节TGF-β信号传递.
- 这些化合物通过影响细胞增殖,细胞亡和血管生成,表现出显著的抗癌活性.
- 植物性天然产品对TGF-β信号通路产生影响,这对癌症发展至关重要.
结论:
- 自然产品通过向TGF-β信号传递,显示出作为补充性癌症治疗的潜力.
- 用天然化合物调节TGF-β可能会改善患者的治疗结果和生活质量.
- 需要进一步的研究和临床评估,以将天然产品纳入常规癌症治疗中.
相关概念视频
01:16TGF - β Signaling Pathway
7.7K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.7K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.8K
01:24Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
01:19Interactions Between Signaling Pathways
6.6K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K
01:22PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K